Search Results - "Guicciardi, Maria E"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis by Kakisaka, Keisuke, Cazanave, Sophie C, Fingas, Christian D, Guicciardi, Maria E, Bronk, Steven F, Werneburg, Nathan W, Mott, Justin L, Gores, Gregory J

    “…Isolated hepatocytes undergo lipoapoptosis, a feature of hepatic lipotoxicity, on treatment with saturated free fatty acids (FFA) such as palmitate (PA)…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice by Feldstein, Ariel E, Canbay, Ali, Guicciardi, Maria E, Higuchi, Hajime, Bronk, Steven F, Gores, Gregory J

    Published in Journal of hepatology (01-12-2003)
    “…Background/Aims: Hepatic steatosis sensitizes the liver to injury and inflammation by unclear mechanisms. Because Fas has been linked to liver injury and…”
    Get full text
    Journal Article
  4. 4

    A smac mimetic reduces TNF Related Apoptosis Inducing Ligand (TRAIL)‐induced invasion and metastasis of cholangiocarcinoma cells by Fingas, Christian D., Blechacz, Boris R. A., Smoot, Rory L., Guicciardi, Maria E., Mott, Justin, Bronk, Steve F., Werneburg, Nathan W., Sirica, Alphonse E., Gores, Gregory J.

    Published in Hepatology (Baltimore, Md.) (01-08-2010)
    “…Cholangiocarcinoma (CCA) cells paradoxically express tumor necrosis factor–related apoptosis‐inducing ligand (TRAIL), a death ligand that, failing to kill CCA…”
    Get full text
    Journal Article
  5. 5

    Hedgehog inhibition promotes a switch from Type II to Type I cell death receptor signaling in cancer cells by Kurita, Satoshi, Mott, Justin L, Cazanave, Sophie C, Fingas, Christian D, Guicciardi, Maria E, Bronk, Steve F, Roberts, Lewis R, Fernandez-Zapico, Martin E, Gores, Gregory J

    Published in PloS one (31-03-2011)
    “…TRAIL is a promising therapeutic agent for human malignancies. TRAIL often requires mitochondrial dysfunction, referred to as the Type II death receptor…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Myofibroblast‐derived PDGF‐BB promotes hedgehog survival signaling in cholangiocarcinoma cells by Fingas, Christian D., Bronk, Steven F., Werneburg, Nathan W., Mott, Justin L., Guicciardi, Maria E., Cazanave, Sophie C., Mertens, Joachim C., Sirica, Alphonse E., Gores, Gregory J.

    Published in Hepatology (Baltimore, Md.) (01-12-2011)
    “…Cholangiocarcinoma (CCA) cells paradoxically express the death ligand, tumor necrosis factor–related apoptosis‐inducing ligand (TRAIL) and, therefore, are…”
    Get full text
    Journal Article
  8. 8

    A Klothoβ Variant Mediates Protein Stability and Associates With Colon Transit in Irritable Bowel Syndrome With Diarrhea by Wong, Banny S, Camilleri, Michael, Carlson, Paula J, Guicciardi, Maria E, Burton, Duane, McKinzie, Sanna, Rao, Archana S, Zinsmeister, Alan R, Gores, Gregory J

    Published in Gastroenterology (New York, N.Y. 1943) (01-06-2011)
    “…Background & Aims Bile acid (BA) malabsorption of moderate severity is reported in 32% of patients with chronic unexplained diarrhea, including…”
    Get full text
    Journal Article
  9. 9

    IL-17 signaling in primary sclerosing cholangitis patient-derived organoids by Garcia Moreno, Ana S, Guicciardi, Maria E, Wixom, Alexander Q, Jessen, Erik, Yang, Jingchun, Ilyas, Sumera I, Bianchi, Jackie K, Pinto E Vairo, Filippo, Lazaridis, Konstantinos N, Gores, Gregory J

    Published in Hepatology communications (01-06-2024)
    “…The pathogenesis of primary sclerosing cholangitis (PSC) is unclear, although studies implicate IL-17A as an inflammatory mediator in this disease. However, a…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Overexpression of Mcl-1 Attenuates Liver Injury and Fibrosis in the Bile Duct-Ligated Mouse by Kahraman, Alisan, Mott, Justin L, Bronk, Steven F, Werneburg, Nathan W, Barreyro, Fernando J, Guicciardi, Maria E, Akazawa, Yuko, Braley, Karen, Craig, Ruth W, Gores, Gregory J

    Published in Digestive diseases and sciences (01-09-2009)
    “…Hepatocyte apoptosis contributes to liver injury and fibrosis after cholestatic injury. Our aim was to ascertain if the anti-apoptotic protein Mcl-1 alters…”
    Get full text
    Journal Article
  12. 12

    Abstract 4105: Hedgehog inhibition promotes type I TRAIL cytotoxicity in human cholangiocarcinoma cells by Kurita, Satoshi, Mott, Justin L., Fernandez-Zapico, Martin E., Bronk, Steve F., Guicciardi, Maria E., Roberts, Lewis R., Hibi, Toshifumi, Gores, Gregory J.

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…Abstract [Background and Aim] TRAIL is a promising therapeutic agent for human malignancies that can activate apoptosis via mitochondria-independent (Type I)…”
    Get full text
    Journal Article
  13. 13